News

Article

Jubilant HollisterStier Sterile Expansion Project Continues

Jubilant HollisterStier added an ampul filling line utilizing a rigid barrier system.

Jubilant HollisterStier has completed the first phase of a sterile-manufacturing capacity expansion at the company’s Montreal-based manufacturing facility with the addition of a new ampoule filling line utilizing a rigid barrier system. The new manufacturing area will expand ampoule manufacturing capacity in Montreal by nearly 200%. In addition, expansions to the sterile areas at Jubilant HollisterStier have been optimized through implementation of lean and six-sigma initiatives.

The new area is scheduled to be ready for product on Sept. 9, 2013. A significant portion of the expanded capacity has already been allocated to new customer products that will be manufactured at the site. Jubilant HollisterStier is a subsidiary of Jubilant Life Sciences, an integrated pharmaceutical and life sciences company headquartered in India.

Source: Jubilant HollisterStier

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
 Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Tariffs & Trade Policy: Results of a Bio/Pharma Peer Survey